JavaScript is disabled in your browser. Please enable JavaScript to view this website.

SPP1

GeneName

SPP1

Summary

SPP1, also known as OPN or IMP, is a 35kDa secreted glycoprotein that plays a multifaceted role in various biological processes. It is primarily expressed in the extracellular space and is associated with cell projections, the endoplasmic reticulum lumen, and the Golgi apparatus. SPP1 functions as a cytokine and is involved in integrin binding, extracellular matrix interactions, and small molecule binding. Its biological activities encompass cell adhesion, osteoblast differentiation, and the regulation of bone resorption, as well as responses to steroid hormones and various stimuli such as testosterone and vitamin D.

Importance

SPP1 is relevant to: - Bone metabolism and pathology, particularly in conditions like osteoporosis due to its role in osteoblast differentiation and bone resorption regulation. - Cancer biology, as it influences tumour progression and metastasis through its interactions with the extracellular matrix and immune modulation. - Wound healing and tissue regeneration, given its involvement in cell adhesion and migration processes. - Endocrine regulation, particularly in the context of steroid hormones and their effects on cellular responses.

Top Products

For researchers investigating SPP1, we recommend two excellent primary antibodies. The first is the well-cited polyclonal antibody, Anti-Osteopontin antibody (ab8448), which has garnered 496 citations, highlighting its reliability in immunohistochemistry (IHC). This antibody is a trusted choice for those focusing on SPP1 detection in tissue samples. Additionally, we offer the recombinant antibody, Anti-Osteopontin antibody [EPR21139-316] (ab214050). This product has been validated for use in multiple applications, including Western blotting (WB), IHC, immunocytochemistry (ICC), and immunoprecipitation (IP). With 85 citations, it is also gaining traction in the research community. The recombinant nature of this antibody ensures batch-to-batch consistency, making it an excellent option for researchers seeking dependable results in their studies of SPP1. "The Human Osteopontin ELISA Kit (ab269374), supported by 6 citations, is an excellent option for researchers looking to accurately measure SPP1 levels in their samples."

Abcam Product Citation Summary

The data indicates that SPP1 is being studied in various contexts, particularly in relation to bone diseases such as Paget's disease, as well as in cancer and fibrosis. The use of multiple species, including humans, rats, and mice, highlights the relevance of SPP1 across different biological models. The applications of Western blotting and immunohistochemistry are prevalent, suggesting a focus on protein expression and localisation in these studies.

Abcam Product Citation Table

ab100618
Human
Paget’s disease of bone
31384515
ab100618
Human
HCV infection and hepatic fibrosis
25760884
ab214050
Human
WB, IHC
Atherosclerotic plaques
31449494
ab63856
Human
WB, IHC
Aorta tissues
27657042
ab63856
Rat
WB, IHC
Vascular smooth muscle cell protein markers
31766280
ab63856
Human
WB
Cancer-associated fibroblasts
31964403
ab8448
Rat
WB
Cardiomyocyte function
25884410
ab8448
Human
IHC
Endometriosis
31239500
ab8448
Human
IHC
Lesional fibrosis
31239500
ab8448
Human
IHC
Gastric cancer specimens
25872762
ab8448
Human
WB
MG63 cells
32334633
ab8448
Human
WB
Dental pulp stem cell cultures
32116788
ab8448
Mouse
WB, IHC
MSC osteoblastic differentiation
31882658
ab8448
Mouse
WB
Endochondral bone development
27039827
ab8448
Rat
WB
Phenotypic switching of VSMCs
30833363
ab8448
Human
WB
A549 cells treated with cisplatin
34187410

Function

Major non-collagenous bone protein that binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction.

Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity.

Post-translational modifications

Forms covalent cross-links mediated by transglutaminase TGM2, between a glutamine and the epsilon-amino group of a lysine residue, forming homopolymers and heteropolymers, increasing its collagen binding properties.

Extensively phosphorylated by FAM20C in the extracellular medium at multiple sites within the S-x-E/pS motif (PubMed:15869464, PubMed:22582013, PubMed:26091039). The phosphorylated form inhibits hydroxyapatite crystallization. Dephosphorylation via a mechanism involving ALPL/TNAP promotes hydroxyapatite crystallization (By similarity).

O-glycosylated. Isoform 5 is GalNAc O-glycosylated at Thr-59 or Ser-62.

Sequence Similarities

Belongs to the osteopontin family.

Tissue Specificity

Detected in cerebrospinal fluid and urine (at protein level) (PubMed:25326458, PubMed:36213313, PubMed:37453717). Bone. Found in plasma.

Cellular localization

Alternative names

BNSP, OPN, PSEC0156, SPP1, Osteopontin, Bone sialoprotein 1, Nephropontin, Secreted phosphoprotein 1, Urinary stone protein, Uropontin, SPP-1

swissprot:P10451 entrezGene:6696 omim:166490

Other research areas